Dan Rossignol

Last updated

Daniel A. Rossignol, MD, FAAFP, is a family medicine doctor. [1] [2] Rossignol runs the Rossignol Medical Center, with offices in Melbourne, Florida and in Aliso Viejo, California. [3] He also works at the Wisconsin Integrative Hyperbaric Center in Fitchburg, Wisconsin, and is a member of the physician advisory board for The Autism Community in Action (TACA; formerly Talk About Curing Autism). [4] Rossignol is known for his advocacy of certain autism therapies. [1] [5]

Contents

Education

Rossignol received his MD from the Virginia Commonwealth University School of Medicine and completed his residency in family medicine at the University of Virginia. [6]

Research

Rossignol's website states that he has published 47 scientific papers, [3] whereas Google Scholar lists 37. Also according to Google Scholar, Rossignol has an h-index of 12. [7] He is best known for publishing randomized clinical trials of hyperbaric oxygen therapy (HBOT) for children with autism, having originally proposed their use for the condition in a 2006 non-peer reviewed paper in Medical Hypotheses . [8] These trials have usually concluded that it is safe, and that it may be effective, but that further study is needed before it can be said to have been proven effective. [9] [10] [11] With regard to one of these studies, published in 2009, Rossignol said, "We wanted to do a formal study that looked to see if this was even a valid treatment," and "We hoped to stimulate more research." [12] He has received the Edgar End Memorial Award from the Undersea and Hyperbaric Medical Society for his HBOT-related research. [6] Some of Rossignol's other research has focused on the prevalence of mitochondrial disease in autistic children, and has concluded that mitochondrial disorders are more common among autistic children than neurotypical children. [13] With regard to this study, Cecilia Giulivi of the University of California, Davis agreed that it appeared from Rossignol's paper that there is indeed a higher incidence of mitochondrial disease among autistic individuals. [14] In addition, Rossignol and Richard E. Frye teamed up to conduct a meta-analysis on the efficacy of melatonin supplements as a treatment for autism. They published their findings in 2011, and while they concluded that it is associated with "improved sleep parameters, better daytime behavior, and minimal side effects," they also called for more research to confirm their findings. [15] [16] A follow-up paper by the same two authors, published on September 20, 2013, as an Epub ahead of print, came to similar conclusions. [17]

Criticism

Rossignol's best-known paper is a clinical trial of HBOT published in 2009, which received widespread media attention. [12] [18] [19] Critics of this research include Steven Novella, who has noted that Rossignol provides HBOT in his clinical practice and therefore "stands to gain personally if its effectiveness is proven." [19] Its methodology was also subject to some criticism, for example by Paul Offit, who argued that "it was possible that at least some parents could tell whether the treatment was active or not, leading to possible observer bias that was not controlled in the study," [20] in contrast to Rossignol et al.'s claim that the parents in the study did not know whether their child had received real HBOT as opposed to the sham version. In addition, John Gever [20] and Steven Novella [19] noted that this study only measured autistic symptoms for four weeks. Additionally, the Committee for the Advancement of Scientific Skepticism wrote that Rossignol's 2009 study "...measured a baseline level of ASD based on three indices [one of which has been discredited] [21] and then measured the degree of improvement within the two groups. There were no comparisons between the placebo and treatment groups, which is essential to determine if there was any benefit for treatment with HBOT. As a result, no firm conclusions about the usefulness of HBOT in the treatment of ASD can be made based on the results of this study." [22] Similarly, Aetna released a policy brief on HBOT in which they stated that, in this study, "There were no significant differences between treatment and control groups in total score, and in the subscales for speech, sociability, and health," [23] and Richard Mills noted that because "children with autism often struggle with other medical issues," "it is difficult to discern exactly which condition hyperbaric therapy might benefit." [24] In response to this criticism, Rossignol has said that "kids who receive the same number of sessions outside of research settings often remain better for longer [than the four week period during which their symptoms were monitored in the study]," [25] and that "You wouldn't anticipate a physician who wasn't doing hyperbaric-oxygen therapy to actually conduct a study of it. Oftentimes when things are new — and this is kind of a new finding — the people who do the studies are going to be those who are involved in it to begin with." [18]

Lawsuit

In 2010, Rossignol was sued in Cook County Circuit Court by James Coman, who alleged that Rossignol, along with another family practice physician, Anjum Usman of Naperville, had administered "dangerous and unnecessary experimental treatments", including chelation therapy, to Coman's son, who was 7 years old at the time. [26]

Personal life

Rossignol is married to Lanier Watkins Rossignol (formerly known as Elizabeth Lanier Watkins). [27] [28] [29] [30] They have two sons, Isaiah and Joshua, both of whom have autism. [31] [32] Lanier has been licensed as a registered nurse since 1996 and resides in Aliso Viejo, California. [33] Rossignol has said he was first introduced to HBOT when his wife suggested using it on their sons, [12] which he then proceeded to do. [34]

Related Research Articles

<span class="mw-page-title-main">Asperger syndrome</span> Neurodevelopmental diagnosis now categorized under Autism Spectrum Disorder

Asperger syndrome (AS), also known as Asperger's syndrome, formerly described a neurodevelopmental disorder characterized by significant difficulties in social interaction and nonverbal communication, along with restricted and repetitive patterns of behavior, interests, and activities. The syndrome has been merged with other disorders into autism spectrum disorder (ASD) and is no longer considered a stand-alone diagnosis. It was considered milder than other diagnoses that were merged into ASD by relatively unimpaired spoken language and intelligence.

A gluten-free casein-free diet, also known as a gluten-free dairy-free diet, is a diet that does not include gluten, and casein. Despite an absence of scientific evidence, there have been advocates for the use of this diet as a treatment for autism and related conditions.

<span class="mw-page-title-main">Hyperbaric medicine</span> Medical treatment at raised ambient pressure

Hyperbaric medicine is medical treatment in which an ambient pressure greater than sea level atmospheric pressure is a necessary component. The treatment comprises hyperbaric oxygen therapy (HBOT), the medical use of oxygen at an ambient pressure higher than atmospheric pressure, and therapeutic recompression for decompression illness, intended to reduce the injurious effects of systemic gas bubbles by physically reducing their size and providing improved conditions for elimination of bubbles and excess dissolved gas.

<span class="mw-page-title-main">Controversies in autism</span> Controversies about both the cause of autism and the nature of the diagnoses themselves

Diagnoses of autism have become more frequent since the 1980s, which has led to various controversies about both the cause of autism and the nature of the diagnoses themselves. Whether autism has mainly a genetic or developmental cause, and the degree of coincidence between autism and intellectual disability, are all matters of current scientific controversy as well as inquiry. There is also more sociopolitical debate as to whether autism should be considered a disability on its own.

<span class="mw-page-title-main">Conditions comorbid to autism spectrum disorders</span> Medical conditions more common in autistic people

Autism spectrum disorders (ASD) are neurodevelopmental disorders that begin in early childhood, persist throughout adulthood, and affect three crucial areas of development: communication, social interaction and restricted patterns of behavior. There are many conditions comorbid to autism spectrum disorders such as attention-deficit hyperactivity disorder and epilepsy.

Son-Rise is a home-based program for children and adults with autism spectrum disorders and other developmental disabilities, which was developed by Barry Neil Kaufman and Samahria Lyte Kaufman for their son Raun, who was diagnosed with autism and is claimed to have fully recovered from his condition. The program is described by Autism Speaks as a "child-centered program that places parents as the key therapists and directors of their program."

The refrigerator mother theory, also known as Bettelheim's theory of autism, is a largely abandoned psychological fringe theory that the cause of autism is a lack of parental, and in particular, maternal emotional warmth. Evidence against the refrigerator mother theory began in the late 1970s, with twin studies suggesting a genetic etiology, as well as various environmental factors. Modern research generally agrees that there is a largely epigenetic etiology of autism spectrum disorders.

High-functioning autism (HFA) was historically an autism classification where a person exhibits no intellectual disability, but may experience difficulty in communication, emotion recognition, expression, and social interaction.

Generation Rescue is a nonprofit organization that advocates the scientifically disproven view that autism and related disorders are primarily caused by environmental factors, particularly vaccines. The organization was established in 2005 by Lisa and J.B. Handley. Today, Generation Rescue is known as a platform for Jenny McCarthy's autism related anti-vaccine advocacy.

<span class="mw-page-title-main">Heritability of autism</span>

The heritability of autism is the proportion of differences in expression of autism that can be explained by genetic variation; if the heritability of a condition is high, then the condition is considered to be primarily genetic. Autism has a strong genetic basis. Although the genetics of autism are complex, autism spectrum disorder (ASD) is explained more by multigene effects than by rare mutations with large effects.

Thiomersal is a mercury compound which is used as a preservative in some vaccines. Anti-vaccination activists promoting the incorrect claim that vaccination causes autism have asserted that the mercury in thiomersal is the cause. There is no scientific evidence to support this claim. The idea that thiomersal in vaccines might have detrimental effects originated with anti-vaccination activists and was sustained by them and especially through the action of plaintiffs' lawyers.

<span class="mw-page-title-main">Causes of autism</span> Proposed causes of autism

The causes of autism are environmental or genetic factors that predispose an individual to develop autism, also known as autism spectrum disorder (ASD). Many causes of autism have been proposed, but understanding of the theory of causation of autism is incomplete. Attempts have been made to incorporate the known genetic and environmental causes into a comprehensive causative framework. ASD is a neurodevelopmental disorder marked by impairments in communicative ability and social interaction and restricted/repetitive behaviors, interests, or activities not suitable for the individual's developmental stage. The severity of symptoms and functional impairment vary between individuals.

Stereotypic movement disorder (SMD) is a motor disorder with onset in childhood involving restrictive and/or repetitive, nonfunctional motor behavior, that markedly interferes with normal activities or results in bodily injury. To be classified as SMD, the behavior in question must not be due to the direct effects of a substance, autism, or another medical condition. The cause of this disorder is not known.

<span class="mw-page-title-main">Autism therapies</span> Therapy aimed at autistic people

Autism therapies include a wide variety of therapies that help people with autism, or their families. Such methods of therapy seek to aid autistic people in dealing with difficulties and increase their functional independence.

Avoidant/restrictive food intake disorder (ARFID) is a feeding or eating disorder in which people avoid eating certain foods, or restrict their diets to the point it ultimately results in nutritional deficiencies. This can be due to the sensory characteristics of food, such as its appearance, smell, texture, or taste; due to fear of negative consequences such as choking or vomiting; having little interest in eating or food, or a combination of these factors. People with ARFID may also be afraid of trying new foods, a fear known as food neophobia.

<span class="mw-page-title-main">Classic autism</span> Neurodevelopmental condition

Classic autism, also known as childhood autism, autistic disorder, (early) infantile autism, infantile psychosis, Kanner's autism,Kanner's syndrome, or (formerly) just autism, is a neurodevelopmental condition first described by Leo Kanner in 1943. It is characterized by atypical and impaired development in social interaction and communication as well as restricted, repetitive behaviors, activities, and interests. These symptoms first appear in early childhood and persist throughout life.

<span class="mw-page-title-main">Autism spectrum</span> Neurodevelopmental disorder

Autism, formally called autism spectrum disorder (ASD) or autism spectrum condition (ASC), is a neurodevelopmental disorder marked by deficits in reciprocal social communication and the presence of restricted and repetitive patterns of behavior. Other common signs include difficulty with social interaction, verbal and nonverbal communication, along with perseverative interests, stereotypic body movements, rigid routines, and hyper- or hyporeactivity to sensory input. Autism is clinically regarded as a spectrum disorder, meaning that it can manifest very differently in each person. For example, some are nonspeaking, while others have proficient spoken language. Because of this, there is wide variation in the support needs of people across the autism spectrum.

James Jeffrey "Jeff" Bradstreet, was an American doctor, alternative medicine practitioner, and a former preacher who ran the International Child Development Resource Center in Melbourne, Florida, a medical practice in Buford, Georgia and in Arizona, where he practiced homeopathy. He also founded the Good News Doctor Foundation, which aimed to combine Christian beliefs with his medical practice.

Richard Eugene Frye is an American autism researcher and associate professor at Arizona Children's Hospital in Phoenix, and formerly of the University of Arkansas for Medical Sciences's department of pediatrics, as well as the Director of the Autism Multispecialty Clinic at Arkansas Children’s Hospital. Frye was formerly a faculty member at the University of Texas Health Science Center at Houston's division of child and adolescent neurology.

The pathophysiology of autism is the study of the physiological processes that cause or are otherwise associated with autism spectrum disorders.

References

  1. 1 2 "On shaky ground with alternative treatments to autism - Los Angeles Times". Articles.latimes.com. 2009-12-07. Retrieved 2014-03-03.
  2. ↑ "Dr. Daniel Rossignol - Melbourne, FL - Family Medicine". Healthgrades. Retrieved 2014-03-03.
  3. 1 2 "Home". Rossignol Medical Center. 2014-02-15. Retrieved 2014-03-03.
  4. ↑ "Dr. Dan Rossignol". TACA. Retrieved 10 September 2021.
  5. ↑ "Doctors sued over 'dangerous' autism treatment - Chicago Tribune". Articles.chicagotribune.com. 2010-03-04. Retrieved 2014-03-03.
  6. 1 2 "Dan Rossignol, MD" . Retrieved 11 October 2013.
  7. ↑ "Dan Rossignol". Google Scholar . Retrieved 15 October 2013.
  8. ↑ Rossignol, D. A.; Rossignol, L. W. (2006). "Hyperbaric oxygen therapy may improve symptoms in autistic children". Medical Hypotheses. 67 (2): 216–228. CiteSeerX   10.1.1.575.2062 . doi:10.1016/j.mehy.2006.02.009. PMID   16554123.
  9. ↑ Rossignol, D. A.; Rossignol, L. W.; Smith, S.; Schneider, C.; Logerquist, S.; Usman, A.; Neubrander, J.; Madren, E. M.; Hintz, G.; Grushkin, B.; Mumper, E. A. (2009). "Hyperbaric treatment for children with autism: A multicenter, randomized, double-blind, controlled trial". BMC Pediatrics. 9: 21. doi: 10.1186/1471-2431-9-21 . PMC   2662857 . PMID   19284641.
  10. ↑ Rossignol, D. A.; Rossignol, L. W.; James, S. J.; Melnyk, S.; Mumper, E. (2007). "The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: An open-label pilot study". BMC Pediatrics. 7: 36. doi: 10.1186/1471-2431-7-36 . PMC   2244616 . PMID   18005455.
  11. ↑ Rossignol, D. A.; Bradstreet, J. J.; Van Dyke, K.; Schneider, C.; Freedenfeld, S. H.; O'Hara, N.; Cave, S.; Buckley, J. A.; Mumper, E. A.; Frye, R. E. (2012). "Hyperbaric oxygen treatment in autism spectrum disorders". Medical Gas Research. 2 (1): 16. doi: 10.1186/2045-9912-2-16 . PMC   3472266 . PMID   22703610.
  12. 1 2 3 Brownstein, Joseph (13 March 2009). "Hyperbaric Autism Treatment Shows Possible Promise". ABC News . Retrieved 12 October 2013.
  13. ↑ Rossignol, D. A.; Frye, R. E. (2011). "Mitochondrial dysfunction in autism spectrum disorders: A systematic review and meta-analysis". Molecular Psychiatry. 17 (3): 290–314. doi:10.1038/mp.2010.136. PMC   3285768 . PMID   21263444.
  14. ↑ Brooks, Megan (31 January 2011). "Mitochondrial Dysfunction Linked to Autism". Medscape . Retrieved 11 October 2013.
  15. ↑ Rossignol, D. A.; Frye, R. E. (2011). "Melatonin in autism spectrum disorders: A systematic review and meta-analysis". Developmental Medicine & Child Neurology. 53 (9): 783–92. doi: 10.1111/j.1469-8749.2011.03980.x . PMID   21518346.
  16. ↑ "Treatment of Melatonin Dysfunction in Children With Autism Shows Improvement in Sleep and Daytime Behaviors". PR Newswire . 26 April 2011. Retrieved 15 October 2013.
  17. ↑ Rossignol, D. A.; Frye, R. E. (2013). "Melatonin in Autism Spectrum Disorders". Current Clinical Pharmacology. 9 (4): 326–34. doi:10.2174/15748847113086660072. PMID   24050742.
  18. 1 2 Anderson, Pauline (2 April 2009). "Hyperbaric Therapy May Improve Autism Symptoms". Medscape . Retrieved 12 October 2013.
  19. 1 2 3 Novella, Steven (16 March 2009). "Hyperbaric Oxygen for Autism". Neurologica Blog. Retrieved 12 October 2013.
  20. 1 2 Gever, John (12 March 2009). "Hyperbaric Therapy Called Effective Against Autism". MedPage Today . Retrieved 9 January 2019.
  21. ↑ Granpeesheh, D.; Tarbox, J.; Dixon, D. R.; Wilke, A. E.; Allen, M. S.; Bradstreet, J. J. (2010). "Randomized trial of hyperbaric oxygen therapy for children with autism". Research in Autism Spectrum Disorders. 4 (2): 268–275. doi:10.1016/j.rasd.2009.09.014.
  22. ↑ "Hyperbaric Oxygen Treatment for Autism - Clearing the Air | Committee for the Advancement of Scientific Skepticism". Scientificskepticism.ca. 2010-06-01. Archived from the original on 2014-01-22. Retrieved 2014-03-03.
  23. ↑ "Clinical Policy Bulletin: Hyperbaric Oxygen Therapy". Aetna . Retrieved 15 October 2013.
  24. ↑ Basu, Paroma (13 April 2009). "Experts question study touting hyperbaric therapy for autism". Simons Foundation . Retrieved 17 October 2013.
  25. ↑ Lite, Jordan (13 March 2009). "Can hyperbaric oxygen therapy help autistic kids?". Scientific American . Retrieved 11 October 2013.
  26. ↑ Callahan, Patricia (4 March 2010). "Doctors sued over 'dangerous' autism treatment". Chicago Tribune . Retrieved 11 October 2013.
  27. ↑ "Elizabeth L Rossignol, Age 42 – Free address, phone, and more on Advanced Background Checks (160035567)". Advancedbackgroundchecks.com. Retrieved 2014-03-03.
  28. ↑ "Elizabeth Rossignol, Melbourne Florida - Instant Checkmate". Archived from the original on 2014-03-04.
  29. ↑ "Daniel Rossignol: More funding needed to study autism". Ocregister.com. 2013-10-19. Retrieved 2014-03-03.
  30. ↑ Rossignol DA (2013). "My Experience Learning About Autism". Glob Adv Health Med. 2 (6): 74–7. doi:10.7453/gahmj.2013.090. PMC   3865379 . PMID   24349885.
  31. ↑ "About Us". ICDRC. Retrieved 11 October 2013.
  32. ↑ Rossignol, Dan (18 October 2013). "More funding needed to study autism". OC Register . Retrieved 1 November 2013.
  33. ↑ "License Lookup". Secure01.virginiainteractive.org. 1996-07-22. Retrieved 2014-03-03.
  34. ↑ Diffin, Elizabeth (23 April 2009). "Hyperbaric therapy shows promise for autism treatment". Medill Reports Chicago. Medill School of Journalism. Archived from the original on 27 April 2009. Retrieved 12 October 2013.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.